VR Logo

Catalyst Pharmaceuticals Inc. (CPRX) download report


Healthcare | Biotechnology & Pharma Research

Catalyst Pharmaceuticals Inc. (CPRX) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States.

IPO Date: 08-Nov-2006

Co-Founder, Chairman, Pres & CEO: Mr. Patrick J. McEnany

Chief Accounting Officer, VP, Treasurer & CFO: Ms. Alicia Grande C.M.A., CPA, CMA, CPA

Listing: NASDAQ: CPRX

Country: United States

Headquarters: Coral Gables, FL

Website: https://www.catalystpharma.com

Key Facts

Market cap: $682.46 Mln

Revenue (TTM): $81.40 Mln

Earnings (TTM): $45.06 Mln

Cash: $197.80 Mln

Total Debt: $4.13 Mln

Insider's Holding: 7.54%

Liquidity: Low

52 Week range: $4.81 - 8.65

Shares outstanding: 102,780,000

10 Years Aggregate:

  • CFO: $36.63 Mln
  • EBITDA: $6.88 Mln
  • Net Profit: $23.88 Mln

Stock Performance

Time Period Catalyst Pharmaceuticals (CPRX) S&P BSE Sensex S&P Small-Cap 600
YTD2.14-8.74-17.05
1 month-1.50-2.01-4.75
3 months-13.45-7.32-12.65
1 Year14.300.45-16.28
3 Years23.9610.328.01
5 Years19.5611.296.35
10 Years28.8112.1410.55
As on 27-Jun-2022
Year Catalyst Pharmaceuticals (CPRX) S&P Small-Cap 600 S&P BSE Sensex
2021102.6925.2721.99
2020-10.939.5715.75
201995.3120.8614.38
2018-50.70-9.705.87
2017272.3811.7327.91
2016-57.1424.741.95
2015-17.51-3.36-5.03